We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.
A serious shortage protocol (SSP) has been issued across the UK for Utrogestan® 100mg capsules today (19 May 2023).
Consultation on banning conversion therapy, and research reports on the nature, quality and quantity of evidence on its prevalence and practice.
Read about talking therapies and counselling for mental health problems.
How to get a marketing authorisation for an Advanced Therapy Medicinal Product (ATMP) so it can be sold and/or supplied in Great Britain.
Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.
The equality assessment presents the impacts of the introduction of the hormone replacement therapy prescription prepayment certificate (HRT PPC).
Recommendations on leadless cardiac pacemaker therapy from MHRA Expert Advisory Group
Guidance on the main diseases that affect cattle, disease prevention and legal controls in place to protect cattle health.
Product Safety Report for YOFULY Vacuum Therapy Machine presenting a high risk of fire and burns.
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
Casgevy (exagamglogene autotemcel) is based on the innovative gene-editing tool CRISPR, which won its inventors the Nobel Prize in 2020
Directly Observed Therapy involves health workers, community volunteers or family members recording patients taking treatment doses
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.